MedPath

Tissue Engineering Microtia Auricular Reconstruction: in Vitro and in Vivo Studies

Early Phase 1
Completed
Conditions
Microtia
Interventions
Other: Chondrocyte culture with FBS medium
Other: Platelet-rich plasma (PRP)
Registration Number
NCT00958802
Lead Sponsor
Taipei Medical University WanFang Hospital
Brief Summary

Platelet-rich plasma (PRP) has mixed growth factors such as TGF-ß1 and TGF-ß2, vascular epithelial growth factor (VEGF), platelet-derived growth factor (PDGF), and insulin-like growth factor (IGF). These growth factors appear to play an important role in wound healing and are assumed as promoters of tissue regeneration. Moreover, PRP was used as injectable scaffold seeded with chondrocytes to regenerate cartilage. In their previous study, the investigators concluded that growth factors in PRP can effectively react as a growth factor cocktail to induce human nucleus pulposus proliferation and differentiation, and also promote tissue-engineered nucleus pulposus formation. The investigators also have a hypothesis that PRP can promote tissue-engineered microtia auricular cartilage formation. TGF- ß1 exists in the highest concentration and is more important among all of the growth factors released from PRP. So TGF- ß1 can be used as the core ingredient and the indicator for applying PRP in these studies. The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
6
Inclusion Criteria
  • microtia patient
Exclusion Criteria
  • non microtia patient

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Arm AChondrocyte culture with FBS mediumChondrocyte culture with FBS medium
Arm BPlatelet-rich plasma (PRP)Chondrocyte culture with PRP
Primary Outcome Measures
NameTimeMethod
The aim of this study was to compare the histological and biochemical character of microtia chondrocytes treated with and without PRP.4 weeks
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Taipei Medical University, Wan Fang Hospital

🇨🇳

Taipei, Taiwan

© Copyright 2025. All Rights Reserved by MedPath